Regenxbio (RGNX) Invested Capital (2016 - 2025)
Historic Invested Capital for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to $161.5 million.
- Regenxbio's Invested Capital fell 4643.55% to $161.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.5 million, marking a year-over-year decrease of 4643.55%. This contributed to the annual value of $259.7 million for FY2024, which is 1670.97% down from last year.
- Latest data reveals that Regenxbio reported Invested Capital of $161.5 million as of Q3 2025, which was down 4643.55% from $213.7 million recorded in Q2 2025.
- In the past 5 years, Regenxbio's Invested Capital ranged from a high of $764.3 million in Q4 2021 and a low of $161.5 million during Q3 2025
- In the last 5 years, Regenxbio's Invested Capital had a median value of $405.9 million in 2023 and averaged $430.7 million.
- In the last 5 years, Regenxbio's Invested Capital soared by 10232.74% in 2021 and then plummeted by 4643.55% in 2025.
- Quarter analysis of 5 years shows Regenxbio's Invested Capital stood at $764.3 million in 2021, then plummeted by 32.46% to $516.2 million in 2022, then plummeted by 39.61% to $311.7 million in 2023, then fell by 16.71% to $259.7 million in 2024, then plummeted by 37.82% to $161.5 million in 2025.
- Its Invested Capital was $161.5 million in Q3 2025, compared to $213.7 million in Q2 2025 and $274.2 million in Q1 2025.